| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : Population Pharmacokinetics (PK and Pharmacodynamics (PD) of Gatifloxacin (GAT) Plasma and MIddle Ear Fluid (MEF) Concentrations in Pediatric Patients with Acute Otitis Media Treatment Failures (AOM-TF) and/or Recurrent Otitis Media (ROM) | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: E. Leibovitz, Ben-Gurion Univ.; Primary Cognigen Author: CM Rubino
Primary Author: E. Leibovitz, Ben-Gurion University, Beer-Sheva, Israel
Event: ICAAC in Chicago, IL - September 14-17, 2003
Sponsor: Bristol-Myers Squibb
Other Contributors: C. Rubino (2), B. Damle (3), B. Cirincione (2), G. Duncan (4), D. Grasela (3), K. Hamed (5), R. Echols (5), R. Dagan (1)
(1) Ben-Gurion University, Beer-Sheva, Israel; (2) Cognigen Corporation, Buffalo, NY; (3) Bristol-Myers Squibb, Princeton, NJ; (4) Bristol-Myers Squibb, New Brunswick, NJ; (5) Bristol-Myers Squibb, Wallingford, CT
Reprints currently not available.
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : Population Pharmacokinetics (PK and Pharmacodynamics (PD) of Gatifloxacin (GAT) Plasma and MIddle Ear Fluid (MEF) Concentrations in Pediatric Patients with Acute Otitis Media Treatment Failures (AOM-TF) and/or Recurrent Otitis Media (ROM) | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |